We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · December 21, 2020

Detection of BRAF Splicing Variants in Plasma-Derived cfDNA and Extracellular Vesicles of Melanoma Patients Failing Targeted Therapy

Oncotarget

 

Additional Info

Oncotarget
Detection of BRAF Splicing Variants in Plasma-Derived Cell-Free Nucleic Acids and Extracellular Vesicles of Melanoma Patients Failing Targeted Therapy Therapies
Oncotarget 2020 Nov 03;11(44)4016-4027, ME Clark, H Rizos, MR Pereira, AC McEvoy, G Marsavela, L Calapre, K Meehan, O Ruhen, MA Khattak, TM Meniawy, GV Long, MS Carlino, AM Menzies, M Millward, M Ziman, ES Gray

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading